RHOA and non-small cell lung carcinoma: Our studies demonstrate that RhoA acts as an upstream regulator of Wnt/β-catenin signaling and the axis is an important regulatory mechanism in NSCLC metastasis induced by KRASG12V and KRASG12D mutations.